Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02574247 · ClinicalTrials.gov registry record · NA
Role of the Auditory Efferent System in Auditory Perceptual Learning
A NA study, sponsored by VA Loma Linda Health Care System.
- Terminated
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02574247: Clinical Trial NA study, sponsored by VA Loma Linda Health Care System.
NCT02574247 is a NA study that was terminated before completion, run by VA Loma Linda Health Care System. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02574247, a NA study, was terminated before completion, sponsored by VA Loma Linda Health Care System.
- TERMINATED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how changes in speech perception resulting from a computerized auditory training program are related to concurrent changes in auditory brainstem function resulting from the training. It is hypothesized that the degree of improvement in speech perception will be correlated with the degree of change in brainstem function.
Primary Outcome
Decibel difference in medial olivocochlear reflex inhibition computed between final visit and baseline visit, where medial olivocochlear reflex inhibition is quantified as amplitude difference (in decibels) between transient-evoked otoacoustic emissions obtained with versus without broadband noise presented to the contralateral ear.
Interventions
- PROCEDURE Computerized auditory training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2016-03-29 |
| Est. Completion | 2017-05-17 |
| Phase | NA |
Why NCT02574247 stopped before completion
NCT02574247 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Computerized auditory training is the first listed.
NCT02574247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02574247 about?
NCT02574247 is a clinical study titled "Role of the Auditory Efferent System in Auditory Perceptual Learning". The purpose of this study is to determine how changes in speech perception resulting from a computerized auditory training program are related to concurrent changes in auditory brainstem function resulting from the training. It is hypothesized that the degree of improvement in speech perception will...
What is the current status of trial NCT02574247?
This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2016-03-29. Estimated completion is 2017-05-17.
What interventions are being tested in trial NCT02574247?
The interventions under investigation include: Computerized auditory training (PROCEDURE).
Who is sponsoring clinical trial NCT02574247?
This trial is sponsored by VA Loma Linda Health Care System, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02574247's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI